Morepen Laboratories Limited logo

MOREPENLAB

NSE
Morepen Laboratories Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
61.22
0.26 (0.43%)
High VOLATILITY
As on 10 Jul 2026

Price History

Market Cap
₹3.35K Cr
SMALL CAP
P/E Ratio
34.9
Industry
Pharmaceuticals
52-Week Range
52W Low33.05+85.2%
52W High65.12-6.0%
Current Price
61.22
Circuit Limits (20%)
Lower Circuit48.98
Upper Circuit73.46
Reference Price
61.22

Investment Checklist

Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹64.64
Bull Flag on 1D — target ₹72.5
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 45.97 (BUY) with 52.9% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Technical Analysis

Analysis from 2026-07-10

Confidence
53%

Trend

BULLISH
BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20
56.06
EMA50
50.49
EMA200
46.92

Price Action

UPTREND
BULLISH
Higher Highs6
Higher Lows6
Lower Highs3
Lower Lows3

Support & Resistance Levels

Resistance (Above)
63.40
65.12
66.40
Support (Below)
55.50
53.66
51.10
50.38
49.62

Volume Analysis

TrendINCREASING
Change+60.60%
Unusual VolumeNo

Stop Loss Levels

Fixed Risk

1% Risk60.61
3% Risk59.38
5% Risk58.16
7% Risk (Custom)
56.93

Technical Levels

1x ATR (Volatility)58.20
2x ATR (Swing)55.18
3x ATR (Trend)52.16
Immediate Support55.50

Moving Averages

EMA 9 (Short-term)59.37
EMA 20 (Medium-term)56.06
EMA 50 (Trend)50.49
EMA 200 (Long-term)46.92

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹458 Cr₹425.2 Cr₹411.6 Cr₹484.2 Cr
Net Profit₹20.3 Cr₹10.7 Cr₹40.9 Cr₹27.5 Cr
EPS₹0.20₹0.75₹0.50
Operating Profit₹46.3 Cr₹28.6 Cr₹61.2 Cr₹50.1 Cr
ROE
10.21%
ROCE
12.91%
Debt/Equity
0.09
Current Ratio
2.32
OPM
10.35%
NPM
5.68%

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol
Name
Price
Change
P/E Ratio
Market Cap
Sun Pharmaceutical Industries Limited₹1,935.50-0.17%40.2
₹4.64L Cr
Divi's Laboratories Limited₹6,836.00+0.34%70.4
₹1.81L Cr
Torrent Pharmaceuticals Limited₹4,901.50+0.07%77.5
₹1.66L Cr
Cipla Limited₹1,439.40-0.13%30.1
₹1.16L Cr
Zydus Lifesciences Limited₹1,150.80-0.71%23.0
₹1.16L Cr
Lupin Limited₹2,496.30-0.28%21.4
₹1.14L Cr
Mankind Pharma Limited₹2,525.10-0.27%54.3
₹1.04L Cr
Dr. Reddy's Laboratories Limited₹1,244.30-1.99%25.6
₹1.04L Cr
Aurobindo Pharma Limited₹1,564.70-1.43%26.1
₹90.88K Cr
Laurus Labs Limited₹1,537.80+2.02%91.5
₹83.02K Cr
Morepen Laboratories Limited₹61.22+0.43%34.9
₹3.35K Cr

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
29 Aug 2025
Dividend - Re 0.20 Per Share
DIVIDEND
20 Sept 2024
Annual General Meeting
AGM
21 Sept 2023
Annual General Meeting
AGM
19 Sept 2022
Annual General Meeting
AGM
20 Sept 2021
Annual General Meeting
AGM

Announcements

Latest updates

View All
DateDescriptionLink
07 Jul 2026
Resignation of Director/KMP/SMP
07 Jul 2026
Resignation
01 Jul 2026
Press Release
01 Jul 2026
Change in Management
26 Jun 2026
Trading Window

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
26 May 2026
Financial Results/Dividend/Other business matters
26 May 2026
Board Meeting Intimation
22 May 2026
Board Meeting Intimation
10 Feb 2026
Board Meeting Intimation
10 Feb 2026
Financial Results/Other business matters

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for MOREPENLAB

View All
NEWS
negative
Business Standard - Markets 8d ago

Kirloskar Pneumatic Company Ltd leads losers in 'A' group

Morepen Laboratories Ltd, HFCL Ltd, Bank of Baroda and AIA Engineering Ltd are among the other losers in the BSE's 'A' group today, 02 July 2026.

AIAENGBANKBARODABANKINDIABBNPNBETFBSEHFCLHGINFRAKIRLOSINDKIRLPNUMBELMOREPENLABSBIBPBCapital GoodsConstruction
NEWS
positive
Business Standard - Markets 10d ago

Morepen Laboratories commences commercial supplies under its Rs 825 cr CDMO mandate

Morepen Laboratories today issued an update on its recently announced Rs 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs 50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation and qualification stage to commercial execution stage.

MOREPENLABHealthcare
NEWS
neutral
Business Standard - Markets 11d ago

Ola Electric Mobility Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, Paras Defence and Space Technologies Ltd, Arvind Ltd and Capri Global Capital Ltd are among the other gainers in the BSE's 'A' group today, 30 June 2026.

AKCAPITARVINDBSECGCLCPCAPDEFENCEECAPINSUREGLOBALMOREPENLABOLAELECPARASAutomobile and Auto ComponentsCapital Goods

Frequently Asked Questions